Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...

We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look ...

Trump's upcoming tariffs has the potential to bring biopharma manufacturing to the US, which could impact companies with ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Beyond computer science laboratories and the big Silicon Valley companies, artificial intelligence is now becoming more ...

Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions ...

Vertex Pharmaceuticals reported revenues of $2.91 billion ... Moderna reported revenues of $966 million, down 65.6% year on ...

The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this. Whatever happens, though ...

The equity portion of the Abrdn Healthcare Investors Fund fell (gross of fees) but outperformed its custom benchmark over the ...

Vertex, nearing finish line for non-opioid drug, delves into current difficulties in pain treatment People with the genetic kidney disease can present with a range of conditions, including FSGS ...